Autologous Mesenchymal Stem Cells for Treatment of Chronic Active Antibody-Mediated Kidney Graft Rejection: Report of the Phase I/II Clinical Trial Case Series.
Večerić-Haler Ž, Sever M, Kojc N, Halloran PF, Boštjančič E, Mlinšek G, Oblak M, Poženel P, Švajger U, Hartman K, Kneževič M, Barlič A, Girandon L, Aleš Rigler A, Zver S, Buturović Ponikvar J, Arnol M.
Večerić-Haler Ž, et al. Among authors: oblak m.
Transpl Int. 2022 Nov 22;35:10772. doi: 10.3389/ti.2022.10772. eCollection 2022.
Transpl Int. 2022.
PMID: 36484064
Free PMC article.
Clinical Trial.